Article

Fibrin tissue adhesive has benefits in pterygium surgery

Washington, DC—Fibrin tissue adhesive (Tisseel VH Fibrin Sealant, Baxter BioSurgery) is a viable and attractive alternative to suturing in pterygium surgery with conjunctival-limbal autograft, said John A. Hovanesian, MD, at the World Cornea Congress V.

Washington, DC-Fibrin tissue adhesive (Tisseel VH Fibrin Sealant, Baxter BioSurgery) is a viable and attractive alternative to suturing in pterygium surgery with conjunctival-limbal autograft, said John A. Hovanesian, MD, at the World Cornea Congress V.

In the first study, statistically significant differences favored fibrin tissue adhesive over sutures for shorter operative time (13 versus 21 minutes, respectively) and for lessening pain after surgery. While patients in 38% of sutured cases rated their pain as moderate to severe, only 4% of cases performed with the fibrin adhesive were associated with that level of pain. In addition, the proportion of cases associated with no pain was nearly two-fold greater in the fibrin tissue adhesive group versus in the eyes with sutures, 41% versus 23%, respectively.

"Pterygium surgery is frequently combined with use of a conjunctival-limbal autograft because that technique is associated with a low rate of recurrence. Unfortunately, sutures used to fix the graft can cause significant postoperative inflammation," said Dr. Hovanesian, clinical instructor, Jules Stein Eye Institute, UCLA, Los Angeles.

Attention to technique Dr. Hovanesian's technique for the surgery begins with a standard excision of the pterygium from the cornea and conjunctiva, taking no more than a 1-mm margin of normal conjunctiva. Then, a thin conjunctival autograft is taken from the superior limbus region using careful dissection to ensure an adequate complement of limbal stem cells is harvested while leaving Tenon's fascia in place as much as possible.

The harvested graft is inverted to lay epithelium against corneal epithelium, cut free with Vannas scissors, and moved in a limbus-to-limbus configuration near the bare sclera site.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.